Amylin (8-37), rat, mouse – 1 mg

Overview

Amylin (8-37) is a critical peptide for researchers studying metabolic processes in both rats and mice. This truncated version of rat amylin operates as a specific amylin antagonist. By blocking the amylin-induced inhibition of glycogen synthesis in muscle, it provides valuable insights into insulin sensitivity and lipid metabolism. If you’re investigating metabolic dynamics or insulin resistance, this peptide could be a vital addition to your research toolkit.

Key Features

• Truncated peptide of native rat amylin
• Acts as a specific amylin antagonist
• Blocks amylin-induced inhibition of glycogen synthesis
• Increases whole body and muscle insulin sensitivity
• Reduces basal insulin levels in insulin-resistant models
• Affects in-vivo lipid metabolism

Specifications

FAQ

What is Amylin (8-37) used for?

Amylin (8-37) is primarily used in research to understand how it influences glycogen synthesis and insulin sensitivity in metabolic studies involving rats and mice.

How does Amylin (8-37) affect insulin levels?

This peptide has been shown to lower basal insulin levels, making it useful in studies focused on insulin resistance and type 2 diabetes.

Can I use Amylin (8-37) in in-vitro studies?

Yes, Amylin (8-37) is effective in in-vitro studies, particularly in isolated muscle tissues, where it demonstrates significant effects on glycogen synthesis.

If you’re looking for high-quality peptides for your research, Amylin (8-37) is available in our Peptides section. Explore our range of products like PKG Substrate and Autocamtide-2 for your specific research needs.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled